0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders

Buy Now

Immunosuppression in Inflammatory Bowel Diseases - Standards, New Developments, Future Trends (Hardcover, 2001 ed.) Loot Price: R4,654
Discovery Miles 46 540
Immunosuppression in Inflammatory Bowel Diseases - Standards, New Developments, Future Trends (Hardcover, 2001 ed.): K....

Immunosuppression in Inflammatory Bowel Diseases - Standards, New Developments, Future Trends (Hardcover, 2001 ed.)

K. Fellermann, DP Jewell, W. J. Sandborn, J. Schoelmerich, E. F. Stange

Series: Falk Symposium, 119

 (sign in to rate)
Loot Price R4,654 Discovery Miles 46 540 | Repayment Terms: R436 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

The aetiology of the chronic inflammatory bowel diseases - Crohn's disease and ulcerative colitis - is still enigmatic. The therapeutic approach has therefore traditionally focused on anti-inflammatory principles, including corticosteroids and aminosalicylates. Since a significant proportion of patients is steroid-dependent or refractory and because of the problematic side-effects of long-term systemic steroids, active immunosuppression has gained acceptance in the field. The classical immunosuppressants azathioprine and 6-mercaptopurine have long been evidence-based in IBD, but underused. Recently, methotrexate and cyclosporine have also been proven to be effective in certain situations. Newer drugs like tacrolimus, mycophenolate and others may be similarly useful but their potential is still unclear. Finally, the immune modifiers including IL-10 and TNF-antibodies have been successfully subjected to controlled trials. Other experimental drugs discussed in this book are on the horizon. This volume is the Proceedings of Falk Symposium 119 held in Freiburg-im-Breisgau, Germany, October 3-4, 2000, and covers systematically the field of immunosuppression in inflammatory bowel diseases. It is hoped that it will further the prudent use of these drugs in the proper clinical situations by increasing our understanding of both the mechanisms of action and the clinical benefit to the patient.

General

Imprint: Springer
Country of origin: Netherlands
Series: Falk Symposium, 119
Release date: 2001
First published: 2001
Editors: K. Fellermann • DP Jewell • W. J. Sandborn • J. Schoelmerich • E. F. Stange
Dimensions: 235 x 155 x 17mm (L x W x T)
Format: Hardcover
Pages: 260
Edition: 2001 ed.
ISBN-13: 978-0-7923-8767-1
Categories: Books > Medicine > Clinical & internal medicine > Gastroenterology
Books > Medicine > Clinical & internal medicine > Diseases & disorders > General
LSN: 0-7923-8767-8
Barcode: 9780792387671

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners